Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays.

Journal of clinical microbiology - 1 Nov 2016

Rebolj Matejka, Bonde Jesper, Preisler Sarah, Ejegod Ditte, Rygaard Carsten, Lynge Elsebeth

Abstract excerpt

Laboratories now can choose from >100 human papillomavirus (HPV) assays for cervical screening. Our previous analysis based on the data from the Danish Horizon study, however, showed that four widely used assays, Hybrid Capture 2 (HC2), cobas, CLART, and Aptima, frequently do not detect the same HPV infections. Here, we determined the characteristics of the concordant samples (all four assays returning a positive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Cervical Cancer and HPV Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Denmark

Share to Early Detection of Cancer

Share to Genotype

Share to Papillomaviridae

Share to Uterine Cervical Dysplasia

Source

Open in PubMed Open full text

Identifiers

PMID: 27535689
DOI: 10.1128/JCM.01321-16
PMCID: PMC5078541

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays.PMID 27535689Read ↗

Comparison of three human papillomavirus DNA assays and one mRNA assay in women with abnormal cytologySemantic proximity Read ↗

Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study.Semantic proximity Read ↗

Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes.Semantic proximity Read ↗

Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study.Semantic proximity Read ↗

Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix.Semantic proximity Read ↗

A direct comparison of four high risk human papilloma virus tests versus the cobas test for detecting cervical intraepithelial neoplasia and cervical cancerSemantic proximity Read ↗

Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.Semantic proximity Read ↗

Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening.Semantic proximity Read ↗

High risk human papillomavirus genotyping in clinical samples: evaluation of different commercial tests.Semantic proximity Read ↗

HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 human papillomavirus genotype microarray system.Semantic proximity Read ↗

Comparative evaluation of three commercial systems for detection of high-risk human papillomavirus in cervical and vaginal ThinPrep PreservCyt samples and correlation with biopsy results.Semantic proximity Read ↗

Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.